NCT00331760 · OUTCOME
Rate of Disease-free Survival at Five Years
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- percentage of participants
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- From registration five years
What was measured
Disease-free survival time is defined as time from registration to date of failure (any tumor recurrence, development of distant metastases or death from any cause) and is estimated by the Kaplan-Meier method. Patients last known to be alive without failure are censored at the date of last contact.
Analysis population: Eligible patients who started study treatment
Groups in this outcome
Endometrial Cancer: IMRT
Endometrial Cancer patients receive Intensity Modulated Radiation Therapy (IMRT)
Cervical Cancer: IMRT + Chemotherapy (Cisplatin)
Cervical patients receive Intensity Modulated Radiation Therapy (IMRT) + Chemotherapy (cisplatin)
| Group | Source count |
|---|---|
| Endometrial Cancer: IMRT | 43 |
| Cervical Cancer: IMRT + Chemotherapy (Cisplatin) | 40 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Endometrial Cancer: IMRT | 88 | Not reported | 74 | 95 | Not reported |
| Cervical Cancer: IMRT + Chemotherapy (Cisplatin) | 84 | Not reported | 68 | 92 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 74
- upper Limit
- 95
- value
- 88
- group Id
- OG001
- lower Limit
- 68
- upper Limit
- 92
- value
- 84
- denoms
- counts
- group Id
- OG000
- value
- 43
- group Id
- OG001
- value
- 40
- units
- Participants
- description
- Disease-free survival time is defined as time from registration to date of failure (any tumor recurrence, development of distant metastases or death from any cause) and is estimated by the Kaplan-Meier method. Patients last known to be alive without failure are censored at the date of last contact.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Endometrial Cancer patients receive Intensity Modulated Radiation Therapy (IMRT)
- id
- OG000
- title
- Endometrial Cancer: IMRT
- description
- Cervical patients receive Intensity Modulated Radiation Therapy (IMRT) + Chemotherapy (cisplatin)
- id
- OG001
- title
- Cervical Cancer: IMRT + Chemotherapy (Cisplatin)
- param Type
- NUMBER
- population Description
- Eligible patients who started study treatment
- reporting Status
- POSTED
- time Frame
- From registration five years
- title
- Rate of Disease-free Survival at Five Years
- type
- SECONDARY
- unit Of Measure
- percentage of participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle